1016 related articles for article (PubMed ID: 31354731)
1. Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases.
An N; Gao Y; Si Z; Zhang H; Wang L; Tian C; Yuan M; Yang X; Li X; Shang H; Xiong X; Xing Y
Front Immunol; 2019; 10():1592. PubMed ID: 31354731
[TBL] [Abstract][Full Text] [Related]
2. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
[TBL] [Abstract][Full Text] [Related]
3. Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases.
Liu D; Zeng X; Li X; Mehta JL; Wang X
Basic Res Cardiol; 2018 Jan; 113(1):5. PubMed ID: 29224086
[TBL] [Abstract][Full Text] [Related]
4. NLRP3: A Novel Mediator in Cardiovascular Disease.
Zhou W; Chen C; Chen Z; Liu L; Jiang J; Wu Z; Zhao M; Chen Y
J Immunol Res; 2018; 2018():5702103. PubMed ID: 29850631
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
6. NLRP3 Inflammasome and Its Central Role in the Cardiovascular Diseases.
Tong Y; Wang Z; Cai L; Lin L; Liu J; Cheng J
Oxid Med Cell Longev; 2020; 2020():4293206. PubMed ID: 32377298
[TBL] [Abstract][Full Text] [Related]
7. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
Takahashi M
J Cardiovasc Pharmacol; 2019 Sep; 74(3):188-193. PubMed ID: 31356542
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway.
Yin Y; Zhou Z; Liu W; Chang Q; Sun G; Dai Y
Int J Biochem Cell Biol; 2017 Mar; 84():22-34. PubMed ID: 28064010
[TBL] [Abstract][Full Text] [Related]
9. Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases.
Zhang X; Xu A; Lv J; Zhang Q; Ran Y; Wei C; Wu J
Eur J Med Chem; 2020 Jan; 185():111822. PubMed ID: 31699536
[TBL] [Abstract][Full Text] [Related]
10. Role of pyroptosis in cardiovascular disease.
Zhaolin Z; Guohua L; Shiyuan W; Zuo W
Cell Prolif; 2019 Mar; 52(2):e12563. PubMed ID: 30525268
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 inflammasome in endothelial dysfunction.
Bai B; Yang Y; Wang Q; Li M; Tian C; Liu Y; Aung LHH; Li PF; Yu T; Chu XM
Cell Death Dis; 2020 Sep; 11(9):776. PubMed ID: 32948742
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction.
Silvis MJM; Demkes EJ; Fiolet ATL; Dekker M; Bosch L; van Hout GPJ; Timmers L; de Kleijn DPV
J Cardiovasc Transl Res; 2021 Feb; 14(1):23-34. PubMed ID: 32648087
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.
Abbate A; Toldo S; Marchetti C; Kron J; Van Tassell BW; Dinarello CA
Circ Res; 2020 Apr; 126(9):1260-1280. PubMed ID: 32324502
[TBL] [Abstract][Full Text] [Related]
14. Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.
Kim JK; Jin HS; Suh HW; Jo EK
Immunol Cell Biol; 2017 Aug; 95(7):584-592. PubMed ID: 28356568
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
16. The role of mitochondria in NLRP3 inflammasome activation.
Liu Q; Zhang D; Hu D; Zhou X; Zhou Y
Mol Immunol; 2018 Nov; 103():115-124. PubMed ID: 30248487
[TBL] [Abstract][Full Text] [Related]
17. Non-canonical Inflammasome-Mediated IL-1β Production by Primary Endometrial Epithelial and Stromal Fibroblast Cells Is NLRP3 and Caspase-4 Dependent.
Kelly P; Meade KG; O'Farrelly C
Front Immunol; 2019; 10():102. PubMed ID: 30804935
[TBL] [Abstract][Full Text] [Related]
18. Role of NLRP3 Inflammasomes in Neuroinflammation Diseases.
Lin S; Mei X
Eur Neurol; 2020; 83(6):576-580. PubMed ID: 33202405
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
[TBL] [Abstract][Full Text] [Related]
20. Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome.
Shim DW; Lee KH
Front Immunol; 2018; 9():1054. PubMed ID: 29868015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
